J&J’s COVID-19 vaccine is “no longer available in the U.S.,” the Centers for Disease Control and Prevention (CDC) said Monday.
The last remaining doses in the U.S. stockpile expired May 7, 2023, with the CDC now giving instructions to “[d]ispose of any remaining Janssen COVID-19 vaccine in accordance with local, state and federal regulations.”
For U.S. adults who received J&J’s shot—either at one or two doses—a follow-up bivalent mRNA dose, either from Moderna or Pfizer and BioNTech, is recommended “at least 2 months after completion of the previous dose,” the CDC said.
J&J, for its part, said via email that it’s “working closely with U.S. regulators to determine the best path forward.”
“Our focus remains on ensuring our vaccine is available to people most in need globally,” a company spokesperson explained.
In the time since J&J’s vaccine scored an emergency nod in the U.S.—the third COVID shot to do so behind Pfizer’s and Moderna’s—some 31.5 million doses have been delivered, with around 19 million of those administered to patients, according to CDC data.
Unlike the more popular mRNA shots, J&J’s only required a single dose for patients to complete their primary vaccine series.
Full Link ( Here )
© CopyRights RawNews1st
